-
サマリー
あらすじ・解説
In this episode, Jack Richardson and Richard Armstrong engage with James Pyre to explore the biotech landscape, delving into his background and the founding of Cambrian. The discussion highlights Cambrian's mission to tackle aging biology and compares biotech to tech investment landscapes. James shares insights into Cambrian's early funding, metabolism research, and drug development efforts. The conversation navigates the complexities of the regulatory environment and data management, emphasizing strategies to accelerate drug development and the future of longevity drugs. The episode wraps up with a quick-fire round of questions with James Pyre, followed by closing remarks.